- Home
- ALTS vs HLVX Comparison
ALTS vs HLVX Comparison
Compare ALTS & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- HLVX
- Stock Information
- Founded
- ALTS 1976
- HLVX 2020
- Country
- ALTS United States
- HLVX United States
- Employees
- ALTS N/A
- HLVX N/A
- Industry
- ALTS
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- HLVX Health Care
- Exchange
- ALTS NYSE
- HLVX Nasdaq
- Market Cap
- ALTS 72.7M
- HLVX 88.7M
- IPO Year
- ALTS N/A
- HLVX 2022
- Fundamental
- Price
- ALTS $4.09
- HLVX $1.73
- Analyst Decision
- ALTS
- HLVX Hold
- Analyst Count
- ALTS 0
- HLVX 5
- Target Price
- ALTS N/A
- HLVX $2.33
- AVG Volume (30 Days)
- ALTS 197.7K
- HLVX 139.8K
- Earning Date
- ALTS 05-02-2025
- HLVX 05-08-2025
- Dividend Yield
- ALTS N/A
- HLVX N/A
- EPS Growth
- ALTS N/A
- HLVX N/A
- EPS
- ALTS N/A
- HLVX N/A
- Revenue
- ALTS $7,110,000.00
- HLVX N/A
- Revenue This Year
- ALTS N/A
- HLVX N/A
- Revenue Next Year
- ALTS N/A
- HLVX N/A
- P/E Ratio
- ALTS N/A
- HLVX N/A
- Revenue Growth
- ALTS N/A
- HLVX N/A
- 52 Week Low
- ALTS $1.29
- HLVX $1.55
- 52 Week High
- ALTS $7.75
- HLVX $18.24
- Technical
- Relative Strength Index (RSI)
- ALTS 33.65
- HLVX 37.55
- Support Level
- ALTS $4.41
- HLVX $1.78
- Resistance Level
- ALTS $4.91
- HLVX $1.91
- Average True Range (ATR)
- ALTS 0.55
- HLVX 0.06
- MACD
- ALTS -0.23
- HLVX -0.00
- Stochastic Oscillator
- ALTS 1.12
- HLVX 5.26
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.